Skip to main content
. Author manuscript; available in PMC: 2016 Jan 31.
Published in final edited form as: J Mol Cell Cardiol. 2014 Nov 13;79:133–144. doi: 10.1016/j.yjmcc.2014.11.003

Figure 3. TGFβ2 modulates proliferation and growth of EMCMs.

Figure 3

A. The addition of 1 ng/mg Tgf-β2 during stretch results in 20% reduction in proliferation (1 +/− 0.05 vs 0.80 +/− 0.05; p<0.05; n=3). B. Embryonic cardiomyocytes treated with ITD-1, a Tgfβr2 inhibitor, are 69% larger (1.40×106 +/−0.10 vs 0.83×106+/− 0.03; p<0.001; n=3).